Share Name |
Share Symbol |
Market |
Type |
Vericel Corporation |
NASDAQ:VCEL |
NASDAQ |
Common Stock |
|
Price Change |
% Change |
Share Price |
Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
Shares Traded |
Last Trade |
|
0.33 |
0.73% |
45.78 |
43.79 |
46.46 |
46.35 |
45.40 |
45.66 |
284,638 |
22:33:36 |
Questcor Pharmaceuticals (QCOR) Shows Strength: Stock Surges 18.7% in Session - Tale of the Tape
08/04/2014 1:44pm
Zacks
Questcor Pharmaceuticals, Inc. (QCOR) was a big mover last session, as the company saw its shares shoot up nearly 19% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend for the company, as the stock is now trading above the volatile price range of $61.06 to $72.17 in the past one-month time frame.
In the last 30 days, this biopharmaceutical company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.
Questcor Pharmaceuticals currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Other players in the healthcare industry include Alexion Pharmaceuticals, Inc. (ALXN), ANI Pharmaceuticals, Inc. (ANIP) and Aastrom Biosciences, Inc. (ASTM) all carrying a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
ALEXION PHARMA (ALXN): Free Stock Analysis Report
ANI PHARMACEUT (ANIP): Free Stock Analysis Report
AASTROM BIOSCI (ASTM): Get Free Report
QUESTCOR PHARMA (QCOR): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
1 Year Vericel Chart
|
1 Month Vericel Chart
|